In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Randomised, Double-Blinded, Multi-Centre, Placebo-Controlled Trial of Deep Brain Stimulation for Essential Tremor

    Final Number:
    162

    Authors:
    Jonathan A. Hyam MRCS BSc; Shazia Javed MB ChB, MRCS; Erlick A.C. Pereira MA BM BCh; Puneet Plaha FRCS, MS; Lucy Mooney BS; Beth Forrow; Carole Joint; Alan Whone MBChB, MRCS, PhD; Steven Gill FRCS, MS; Alexander L. Green MBBS, BSc; Tipu Z. Aziz

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2011 Annual Meeting

    Introduction: Deep brain stimulation (DBS) for intractable essential tremor (ET) has yet to be evaluated by a randomised placebo-controlled trial. We applied three statistical methods to evaluate DBS efficacy in ET: 1) traditional randomised prospective cohort analysis; 2) N-of-1 single patient randomised control trials; 3) Signal-to-noise (S2N) analysis (1).

    Methods: ET patients receiving thalamic or zona incerta stimulation were studied. Stimulation was switched-off and maximal tremor severity (2) reached. Stimulation was randomly programmed On unilaterally or Off (placebo) with patient and tremor evaluator blinded. When tremor severity had declined more than 80%, the timed trial was stopped. Patients reported whether they perceived stimulation to be On or not. 6 pairs of trials were performed.

    Results: 21 patients were studied, mean age 67.6 years, mean tremor duration 382.7 months and time since surgery 1186 days. 1) Mean time until tremor attenuation was 25.3 seconds (SD+71.9) On versus 126.3 seconds (SD+75.6) Off, z=-3.808, p<0.0005. Mean end-of-trial tremor severity was 0.84 (SD+0.75) On and 6.62 (SD+1.87) Off, t=-13.218, p<0.0005. 2) N-of-1: Mean number of correct perceptions was 11.2/12, a probability of p<0.030. 60% of patients had 12 correct perceptions (p=0.001), 20% had 11 correct perceptions (p=0.013). Within each patient, tremor severity was better On versus Off, significant (p<0.05) in 78.9% of patients. 3) S2N: Mean S2N ratio was >10 (i.e. significant) in 100% of 19 patients trialled On (mean 356,927,124, SD+289,004,393) versus 11% of patients Off (mean 44,026,220, SD+38,370,349). Average chance of >80% ET improvement without DBS was therefore <1/350miliion (range 1/ 70 million to 1/1009 million).

    Conclusions: This is the first randomised, placebo-controlled trial of DBS for ET and demonstrates a large treatment effect. N-of-1 and S2N are therefore important, valid, cost-effective alternatives to large trials for proving benefit in patients receiving neurosurgery.

    Patient Care: This study provides a robust evaluation of the efficacy of an invasive cranial surgery and provides evidence to support its use in ET patients for whom medical therapy is not sufficiently effective. The study also provides the first demonstration of the usefulness of signal-to-noise analyses in surgery which are an alternative to large randomised control trials which may entail sham surgeries or non-surgical therapies that may not be feasible or desirable for medically-intractable patients.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Describe N-of-1 and Signal-to-Noise trials. 2) Appreciate the potential application of these types of trials in the cost-effective evaluation of efficacy of surgical procedures in which a large treatment effect exists. 3) Describe the efficacy of DBS in the treatment of ET.

    References: 1. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334(7589):349-351. 2. Bain PG, Findley LJ, Atchinson P, Behari M, Vidailhet M, Gresty M, Rothwell JC, Thompson PD, Marsden CD. Assessing tremor severity. J Neurology Neurosurgery Psychiatry 1993;56:868-73.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy